← FDA DRUG APPROVALS

FDA ANDA · ANDA085025

HYDROCORTISONE

Sponsor: PADAGIS US

APPLICATION
ANDA085025
TYPE
ANDA
ORIGINAL APPROVAL
1983-04-21
LATEST ACTION
1999-12-27
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

HYDROCORTISONEPrescription
HYDROCORTISONE 2.5% · CREAM · TOPICAL

Approval history

1999-12-27Manufacturing (CMC) · Supplement 18AP
1996-05-08Labeling · Supplement 17AP
1996-05-08Manufacturing (CMC) · Supplement 16AP
1986-06-11Manufacturing (CMC) · Supplement 13AP
1983-04-21OriginalAP
1982-06-30Manufacturing (CMC) · Supplement 8AP
1982-06-02Manufacturing (CMC) · Supplement 9AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →